NM_001042681.2(RERE):c.3556AAGGAG[2] (p.1186KE[2]) AND not provided
- Germline classification:
- Benign (2 submissions)
- Last evaluated:
- Jul 1, 2024
- Review status:
- Somatic classification
of clinical impact: - None
- Review status:
- Somatic classification
of oncogenicity: - None
- Review status:
- Record status:
- current
- Accession:
- RCV000888559.16
Allele description [Variation Report for NM_001042681.2(RERE):c.3556AAGGAG[2] (p.1186KE[2])]
NM_001042681.2(RERE):c.3556AAGGAG[2] (p.1186KE[2])
Condition(s)
- Synonyms:
- none provided
- Identifiers:
- MedGen: C3661900
-
ERP126140 (399)
SRA
-
RNA polymerase II largest subunit, partial [Lecidea cancriformis]
RNA polymerase II largest subunit, partial [Lecidea cancriformis]gi|1806643730|gb|QHW18740.1|Protein
-
Drug Class Review: Triptans
Drug Class Review: Triptans
-
Annual Plasma Utilization - Octaplas Compared with Fresh Frozen Plasma to Reduce...
Annual Plasma Utilization - Octaplas Compared with Fresh Frozen Plasma to Reduce the Risk of Transmitting Lipid-Enveloped Viruses: An Economic Analysis and Budget Impact Analysis
-
GRB2-associated-binding protein 2 isoform 2 [Mus musculus]
GRB2-associated-binding protein 2 isoform 2 [Mus musculus]gi|247270076|ref|NP_001155949.1|Protein
Your browsing activity is empty.
Activity recording is turned off.
See more...Assertion and evidence details
Last Updated: Sep 29, 2024